Aquestive Therapeutics Inc (AQST)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Aquestive Therapeutics Inc-Aktie (AQST)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.73% 12.05	13.21	13.00	13.24	11.13
Cost Of Revenue	6.20% 4.389	4.679	4.798	6.617	4.737
Gross Profit	10.12% 7.664	8.527	8.204	6.624	6.397
Operating Expenses	33.63% 16.62	12.44	10.58	10.83	11.00
Interest Income/Expense	22.48% 2.784	2.273	1.256	1.373	1.435
Benefits Costs and Expenses	17.27% 24.88	21.22	15.18	18.75	3.066
Costs And Expenses	22.74% 21.01	17.12	15.38	17.45	15.74
Depreciation and Amortization	55.67% 0.207	0.467	0.264	0.289	0.325
Operating Income/Loss	129.02% -8.957	-3.911	-2.377	-4.209	-4.605
Income/Loss From Continuing Operations Before Tax	60.15% -12.83	-8.01	-2.175	-5.508	8.068
Income Tax Expense/Benefit	100.00% -	0.101	-0.14	0.284	-
Income/Loss From Continuing Operations After Tax	58.16% -12.83	-8.111	-2.035	-5.792	8.068
Net Income/Loss	58.16% -12.83	-8.111	-2.035	-5.792	8.068
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3,575% 73.61	2.0031	64.68	57.35	55.63
Diluted Average Shares	28,647% 73.61	-0.2579	64.68	57.35	73.79
Basic Earnings Per Share	30.77% -0.17	-0.13	-0.03	-0.10	0.15
Diluted Earnings Per Share	30.77% -0.17	-0.13	-0.03	-0.10	0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$12.67

0.88%

LNTH

$114.96

0.42%

ITCI

$89.24

3.56%

CTLT

$58.48

0.36%

NBIX

$121.53

0.83%

VTRS

$11.61

1.40%